IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 130 filers reported holding IMMUNITYBIO INC in Q3 2022. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $107,446 | +29.9% | 17,001 | +10.4% | 0.00% | – |
| Q1 2024 | $82,703 | +35.0% | 15,401 | +26.2% | 0.00% | – |
| Q4 2023 | $61,274 | +203.2% | 12,206 | +2.1% | 0.00% | – |
| Q3 2023 | $20,206 | -43.2% | 11,956 | -6.6% | 0.00% | – |
| Q2 2023 | $35,601 | +40.6% | 12,806 | -8.0% | 0.00% | – |
| Q1 2023 | $25,323 | -61.6% | 13,914 | +6.9% | 0.00% | – |
| Q4 2022 | $65,981 | -8.4% | 13,014 | -10.3% | 0.00% | – |
| Q3 2022 | $72,000 | +41.2% | 14,514 | +6.6% | 0.00% | – |
| Q2 2022 | $51,000 | – | 13,621 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
| ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
| Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
| SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
| Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
| Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
| Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
| Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |